Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients

Cancer Science

Volumn 96, Issue 11, 2005, Pages 801-809

  Matsushita, Hirokazu ^a   Uenaka, Akiko ^a   Ono, Toshiro ^b   Hasegawa, Kosei ^a   Sato, Shuichiro ^a   Koizumi, Fumihito ^a   Nakagawa, Kazuhiko ^a   Toda, Masahiro ^c   Shingo, Tetsuro ^a   Ichikawa, Tomotsugu ^a   Noguchi, Yuji ^a   Tamiya, Takashi ^d   Furuta, Tomohisa ^e   Kawase, Takeshi ^c   Date, Isao ^a   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e KIBI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; REGULATOR PROTEIN; REGULATORY FACTOR X4 E; REGULATORY FACTOR X4 F; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPERMATOCYTE; TESTIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIBODY FORMATION; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTIS; TRANSCRIPTION FACTORS;

EID: 29644439955     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00112.x     Document Type: Article

References (20)

1. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71: 2585-97.
2. Gupta T, Sarin R. Poor-prognosis high-grade gliomas: Evolving an evidence-based standard of care. Lancet Oncol 2002; 3: 557-64.
3. Parney IF, Hao, C, Petruk KC. Glioma immunology and immunotherapy. Neurosurgery 2000; 46: 778-92.
4. Fenstermaker RA, Ciesielski MJ. Immunotherapeutic strategies for malignant glioma. Cancer Control 2004; 11: 181-91.
5. Ehtesham M, Black KL, Yu JS. Recent progress in immunotherapy for malignant glioma: Treatment strategies and results from clinical trials. Cancer Control 2004; 11: 192-207.
6. Boon T, Old LJ. Cancer tumor antigens. Curr Opin Immunol 1997; 9: 681-3.
7. Sahin U, Koslowski M, Tureci O et al. Expression of cancer testis genes in human brain tumors. Clin Cancer Res 2000; 6: 3916-22.
8. Emery P, Durand B, Mach B, Reidi W. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res 1996; 24: 803-7.
9. Gajiwala KS, Chen H, Cornille F et al. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature 2000; 403: 916-21.
10. Morotomi-Yano K, Yano K, Saito H, Sun Z, Iwama A, Miki Y. Human Reguratory Factor X4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX members. J Biol Chem 2002; 277: 836-42.
11. Dotzlaw H, Alkhalaf M, Murphy LC. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol 1992; 6: 773-85.
12. Blackshear PJ, Graves JP, Stumpo DJ, Cobos I, Rubenstein JL, Zeldin DC. Graded phenotypic response to partial and complete deficiency of a brain-specific transcript variant of the winged helix transcription factor RFX4. Development 2003; 130: 4539-52.
13. Araki R, Takahashi H, Fukumura R et al. Restricted expression and photic induction of a novel mouse regulatory factor X4 transcript in the suprachiasmatic nucleus. J Biol Chem 2004; 279: 10237-42.
14. World Health Organization classification of tumours. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000; pp 10-76.
15. Stockert E, Jager E, Chen YT et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998; 187: 1349-54.
16. Chen YT, Scanlan MJ, Sahin U et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997; 94: 1914-8.
17. Kurashige T, Noguchi Y, Saika T et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade. Cancer Res 2001; 61: 4671-4.
18. Struss AK, Romeike BF, Munnia A et al. PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene 2001; 20: 4107-14.
19. Ueda R, Iizuka Y, Yoshida K, Kawase T, Kawakami Y, Toda M. Identification of a human glioma antigen, SOX6, recognized by patients' sera. Oncogene 2004; 23: 1420-7.
20. Jager E, Nagata Y, Gnjatic S et al. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 2000; 97: 4760-5.